See the DrugPatentWatch profile for Menopur
Menopur 75 IU is a prescription medication containing menotropins, used to stimulate ovulation in women with infertility. It is administered via injection and contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH) [1].
Why do women use Menopur 75 IU?
Menopur is prescribed to women who are experiencing infertility. Its primary function is to stimulate the development of ovarian follicles, which contain eggs. This stimulation is a crucial step in assisted reproductive technologies, such as in vitro fertilization (IVF) [1].
How does Menopur 75 IU work?
Menopur contains both FSH and LH, which are gonadotropins naturally produced by the pituitary gland. FSH stimulates the growth and maturation of ovarian follicles, while LH plays a role in ovulation and corpus luteum development. By providing these hormones exogenously, Menopur encourages the ovaries to produce multiple follicles [1].
What is the typical dosage and administration for Menopur 75 IU?
The dosage of Menopur, including the 75 IU strength, is individualized based on a woman's response, as determined by her doctor through monitoring. It is typically administered daily via subcutaneous injection. The duration of treatment varies but often lasts for several days during the menstrual cycle to achieve the desired follicle development [1].
What are the potential side effects of Menopur 75 IU?
Common side effects associated with Menopur include headache, nausea, abdominal pain, bloating, and injection site reactions such as redness, swelling, or bruising. A more serious potential complication is Ovarian Hyperstimulation Syndrome (OHSS), which can cause severe abdominal pain, nausea, vomiting, diarrhea, and rapid weight gain [1].
When does the patent for Menopur expire?
Information regarding the specific patent expiry dates for Menopur can be found on DrugPatentWatch.com [2]. Patent expirations are crucial for determining when generic or biosimilar versions of a drug might become available.
Are there alternative treatments for infertility that use gonadotropins?
Yes, there are other gonadotropin medications available that stimulate follicle development. These can vary in their specific hormone composition (e.g., pure FSH or combinations of FSH and LH) and their administration routes. The choice of medication depends on the individual patient's needs and the fertility specialist's assessment. DrugPatentWatch.com may provide information on the patent status and competitive landscape for these alternatives [2].